Actionable insights straight to your inbox

A Pivotal Moment for Bond Investors

Sign Up For Our Newsletter

Actionable ideas straight to your inbox

  • Investing & Finance, The New Innovators

In 2023: No Excuses, Just Results

Revisiting Freeport-McMoRan … and Bayer

A year before writing about Freeport, I recommended readers buy shares of Bayer AG. Since pitching the idea, the stock is up 12.19%. And guess what? It's still cheap.

Do You Get Equity Compensation? Avoid These 10 Mistakes People Make With Company Stock

The Long List of Pharmaceuticals in Short Supply

Need to Know: Energy Stocks, ’Dirty’ Energy Stocks, the Dollar and Gold

Market Movers

Energy Transitions

Need to Know: Energy Stocks, ’Dirty’ Energy Stocks, the Dollar and Gold

More Sectors to Watch in 2023: Lithium, Green Hydrogen, Uranium

Lithium Was the Best Performing Commodity for the Second Straight Year

Climate Investing Isn’t ‘Woke Capitalism.’ It’s Smart Capitalism

The New Innovators

In 2023: No Excuses, Just Results

  • 3 min Read 
  • 3 min Read

Putting Crypto’s Big Scandal in Context

Nuclear Fusion Technology Could Be a $40 Trillion Market

Silicon Valley ‘Open Secret’ Means Buy This World-Class Tech Stock

Telehealth / Telemedicine: A Sector With More Than a Pulse

Fintech 2.0

Understanding How Much Crypto You Should Have in Your Portfolio During a Down Market

Putting Crypto’s Big Scandal in Context

Bettor Excitement Doesn’t Spare Online Gaming from Critical Investors

Central Bank Digital Currencies May Be Inevitable, and That’s a Problem

A Pivotal Moment for Bond Investors

The Latest

Sign up For our Newsletter

SITEMAP

Contact

© 2022 Equities News | Equities.com, Inc.